Hanafy AS - Search Results

1

Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer's model.

Hanafy AS, Lamprecht A, Dietrich D. Hanafy AS, et al. Fluids Barriers CNS. 2023 Nov 22;20(1):85. doi: 10.1186/s12987-023-00492-7. Fluids Barriers CNS. 2023. PMID: 37993886 Free PMC article.

2

Design of Chronomodulated Drug Delivery System of Valsartan: In Vitro Characterization.

Sokar M, Hanafy A, Elkamel A, El-Gamal S. Sokar M, et al. Indian J Pharm Sci. 2015 Jul-Aug;77(4):470-7. doi: 10.4103/0250-474x.164768. Indian J Pharm Sci. 2015. PMID: 26664064 Free PMC article.

3

CRISPR/Cas9 Delivery Potentials in Alzheimer's Disease Management: A Mini Review.

Hanafy AS, Schoch S, Lamprecht A. Hanafy AS, et al. Pharmaceutics. 2020 Aug 25;12(9):801. doi: 10.3390/pharmaceutics12090801. Pharmaceutics. 2020. PMID: 32854251 Free PMC article. Review.

4

Blood-brain barrier models: Rationale for selection.

Hanafy AS, Dietrich D, Fricker G, Lamprecht A. Hanafy AS, et al. Adv Drug Deliv Rev. 2021 Sep;176:113859. doi: 10.1016/j.addr.2021.113859. Epub 2021 Jul 9. Adv Drug Deliv Rev. 2021. PMID: 34246710 Review.

5

Subcellular analysis of blood-brain barrier function by micro-impalement of vessels in acute brain slices.

Hanafy AS, Steinlein P, Pitsch J, Silva MH, Vana N, Becker AJ, Graham ME, Schoch S, Lamprecht A, Dietrich D. Hanafy AS, et al. Nat Commun. 2023 Jan 30;14(1):481. doi: 10.1038/s41467-023-36070-6. Nat Commun. 2023. PMID: 36717572 Free PMC article.

6

Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges.

Wen MM, El-Salamouni NS, El-Refaie WM, Hazzah HA, Ali MM, Tosi G, Farid RM, Blanco-Prieto MJ, Billa N, Hanafy AS. Wen MM, et al. Among authors: hanafy as. J Control Release. 2017 Jan 10;245:95-107. doi: 10.1016/j.jconrel.2016.11.025. Epub 2016 Nov 23. J Control Release. 2017. PMID: 27889394 Review.

7

Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.

Hanafy AS, Farid RM, ElGamal SS. Hanafy AS, et al. Drug Dev Ind Pharm. 2015;41(12):2055-68. doi: 10.3109/03639045.2015.1062897. Epub 2015 Jul 2. Drug Dev Ind Pharm. 2015. PMID: 26133084

8

Galantamine nanoparticles outperform oral galantamine in an Alzheimer's rat model: pharmacokinetics and pharmacodynamics.

El-Ganainy SO, Gowayed MA, Agami M, Mohamed P, Belal M, Farid RM, Hanafy AS. El-Ganainy SO, et al. Among authors: hanafy as. Nanomedicine (Lond). 2021 Jun;16(15):1281-1296. doi: 10.2217/nnm-2021-0051. Epub 2021 May 20. Nanomedicine (Lond). 2021. PMID: 34013783

9

Novel treatment strategies for brain tumors and metastases.

El-Habashy SE, Nazief AM, Adkins CE, Wen MM, El-Kamel AH, Hamdan AM, Hanafy AS, Terrell TO, Mohammad AS, Lockman PR, Nounou MI. El-Habashy SE, et al. Among authors: hanafy as. Pharm Pat Anal. 2014 May;3(3):279-96. doi: 10.4155/ppa.14.19. Pharm Pat Anal. 2014. PMID: 24998288 Free PMC article. Review.

10

Galantamine transdermal patch shows higher tolerability over oral galantamine in rheumatoid arthritis rat model.

Kandil LS, Hanafy AS, Abdelhady SA. Kandil LS, et al. Among authors: hanafy as. Drug Dev Ind Pharm. 2020 Jun;46(6):996-1004. doi: 10.1080/03639045.2020.1764025. Epub 2020 May 18. Drug Dev Ind Pharm. 2020. PMID: 32378971

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters